Skip to main content

Table 2 Biomarkers investigated with ELISA in sera samples of female U-JDM versus age matched female controls

From: Serum protein biomarkers for juvenile dermatomyositis: a pilot study

8 untreated JDM vs 17 healthy control females

Biomarker Name, (Accession Number)

SomaScan® assay

MSD ELISA assay

Confirm (Yes/No)

Previously reported by others or novel

Fold Change

Adjusted P-value (direction)

Fold Change

Adjusted P-value

CXCL11

(I-TAC)

(O14625)

13.7

<  0.001 (↑)

6.75

< 0.001 (↑)

Yes

[31]

IL-17B (Q9UHF5)

−2.1

< 0.001 (↓)

−2.4

< 0.001 (↓)

Yes

Novel

IL-17D (Q8TAD2)

−1.28

0.002 (↓)

−1.4

0.128 (↓)

No

[32]

IL-22 (Q9GZX6)

62

< 0.001(↑)

4.27

< 0.001 (↑)

Yes

Novel

CXCL10 (IP-10)

(P02778)

11.3

< 0.001 (↑)

16.4

< 0.001 (↑)

Yes

[33]

MCP-1 (P13500)

2.1

< 0.001 (↑)

3.11

0.001 (↑)

Yes

[34]

ANGPT2 (O15123)

3.8

< 0.001 (↑)

2.6

< 0.001 (↑)

Yes

Novel

MIF (P14174)

2.38

< 0.001 (↑)

1.2

0.467 (↑)

No

[35]

IL-23 (P29460, Q9NPF7)

2.22

0.001 (↑)

−1.1

0.306 (↓)

No

Novel

  1. C-X-C motif chemokine 11 (I-TAC or CXCL11), Interleukin-17B (IL-17B), Interleukin-17D (IL-17D), Interleukin-22 (IL-22), C-X-C motif chemokine 10 (IP-10 or CXCL10), C-C motif chemokine 2 (CCL2 or MCP-1), Angiopoietin-2 (ANG-2 or ANGPT2), Macrophage migration inhibitory factor (MIF) and Interleukin-23 (IL-23).